UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

A pre‐existing coordinated inflammatory microenvironment is associated with complete response of vulvar high‐grade squamous intraepithelial lesions to different forms of immunotherapy

International journal of cancer, 2020-11, Vol.147 (10), p.2914-2923

2020

Volltextzugriff (PDF)

Topical imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia lesions (TOPIC-2): A randomised controlled trial

BJOG : an international journal of obstetrics and gynaecology, 2024-03

2024

Volltextzugriff (PDF)

Intraepithelial macrophage infiltration is related to a high number of regulatory T cells and promotes a progressive course of HPV‐induced vulvar neoplasia

International journal of cancer, 2015-02, Vol.136 (4), p.E85-E94

2015

Volltextzugriff (PDF)

The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFκB activation

Nature communications, 2015-03, Vol.6 (1), p.6537-6537, Article 6537

2015

Volltextzugriff (PDF)

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial

Journal of translational medicine, 2013-04, Vol.11 (1), p.88-88, Article 88

2013

Volltextzugriff (PDF)

Importance of the Immune Microenvironment in the Spontaneous Regression of Cervical Squamous Intraepithelial Lesions (cSIL) and Implications for Immunotherapy

Journal of clinical medicine, 2022-03, Vol.11 (5), p.1432

2022

Volltextzugriff (PDF)

Pre-existing inflammatory immune microenvironment predicts the clinical response of vulvar high-grade squamous intraepithelial lesions to therapeutic HPV16 vaccination

Journal for immunotherapy of cancer, 2020-03, Vol.8 (1), p.e000563

2020

Volltextzugriff (PDF)

Expression of coinhibitory receptors on T cells in the microenvironment of usual vulvar intraepithelial neoplasia is related to proinflammatory effector T cells and an increased recurrence‐free survival

International journal of cancer, 2015-02, Vol.136 (4), p.E95-E106

2015

Volltextzugriff (PDF)

Immune-based biomarker accurately predicts response to imiquimod immunotherapy in cervical high-grade squamous intraepithelial lesions

Journal for immunotherapy of cancer, 2022-11, Vol.10 (11), p.e005288

2022

Volltextzugriff (PDF)

Clinical Characteristics Associated With Development of Recurrence and Progression in Usual-Type Vulvar Intraepithelial Neoplasia

International journal of gynecological cancer, 2013-10, Vol.23 (8), p.1476-1483

2013

Volltextzugriff (PDF)

Human Papillomavirus Downregulates the Expression of IFITM1 and RIPK3 to Escape from IFNγ- and TNFα-Mediated Antiproliferative Effects and Necroptosis

Frontiers in immunology, 2016-11, Vol.7, p.496-496

2016

Volltextzugriff (PDF)

366 Core set of patient-reported outcomes in vulvar cancer a Delphi study among patients, partners and health care providers

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A532-A532

2024

Volltextzugriff (PDF)

Treatment failure in patients with HPV 16-induced vulvar intraepithelial neoplasia: understanding different clinical responses to immunotherapy

Expert review of vaccines, 2012-07, Vol.11 (7), p.821-840

2012

Volltextzugriff (PDF)

1020 Prognostic and therapeutic implications of radiologic-clinical discrepancy in parametrial invasion assessments prior to primary radical hysterectomy in cervical cancer

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A146-A146

2024

Volltextzugriff (PDF)

EP094/#1572 Unraveling the complexities of cervical cancer: exploration of molecular mechanisms and immunological dichotomies between squamous cell carcinoma and adenocarcinoma

International journal of gynecological cancer, 2023-11, Vol.33 (Suppl 4), p.A113-A114

2023

Volltextzugriff (PDF)

Unraveling Differences in Molecular Mechanisms and Immunological Contrasts between Squamous Cell Carcinoma and Adenocarcinoma of the Cervix

International journal of molecular sciences, 2024-06, Vol.25 (11), p.6205

2024

Volltextzugriff (PDF)

EP330/#475 Immune-based biomarker accurately predicts response to imiquimod immunotherapy in cervical high-grade squamous intraepithelial lesions

International journal of gynecological cancer, 2022-12, Vol.32 (Suppl 3), p.A187-A188

2022

Volltextzugriff (PDF)

Treatment with methotrexate of a cornual pregnancy following endometrial resection

The European journal of contraception & reproductive health care, 2012-04, Vol.17 (2), p.170-174

2012

Volltextzugriff (PDF)

The immune cell infiltrate in the microenvironment of vulvar Paget disease

Gynecologic oncology, 2018-12, Vol.151 (3), p.453-459

2018

Volltextzugriff (PDF)

The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NF[kappa]B activation

Nature communications, 2015-03, p.6537

2015

Volltextzugriff (PDF)

Human papillomavirus (HPV) downregulates the expression of IFITM1 and RIPK3 to escape from IFNγ and TNFα-mediated anti-proliferative effects and necroptosis

Frontiers in immunology, 2016-11, Vol.7

2016

Volltextzugriff (PDF)

Treatment with methotrexate of a cornual pregnancy following endometrial resection

The European Journal of Contraception & Reproductive Health Care, 2012, Vol.17 (2), p.170-174

2012

Volltextzugriff (PDF)

285 Risk factors for wound complications in vulvar cancer surgery and the impact of reconstructive surgery

International journal of gynecological cancer, 2023-09, Vol.33 (Suppl 3), p.A382-A382

2023

Volltextzugriff (PDF)

339 Improving patient counseling before and during imiquimod treatment for cervical high-grade squamous intraepithelial lesions: a qualitative study

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A578-A578

2024

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(37)
Berichte
(1)

Sprache

Englisch
(38)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(18)
Humans
(14)
Female
(10)
Immunotherapy
(10)
Cancer
(8)
Human Papillomavirus
(8)
Middle Aged
(8)
Oncology
(8)
Immunology
(7)
Adult
(6)
Aged
(6)
Hpv
(6)
Animals
(5)
Cervical Cancer
(5)
Lymphocytes
(5)
Papillomavirus Infections - Immunology
(5)
Poster And E-Posters
(5)
Vulvar Neoplasms - Immunology
(5)
Aged, 80 And Over
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A pre‐existing coordinated inflammatory microenvironment is associated with complete response of vulvar high‐grade squamous intraepithelial lesions to different forms of immunotherapy

Topical imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia lesions (TOPIC-2): A randomised controlled trial

Intraepithelial macrophage infiltration is related to a high number of regulatory T cells and promotes a progressive course of HPV‐induced vulvar neoplasia

The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFκB activation

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial

Importance of the Immune Microenvironment in the Spontaneous Regression of Cervical Squamous Intraepithelial Lesions (cSIL) and Implications for Immunotherapy

Pre-existing inflammatory immune microenvironment predicts the clinical response of vulvar high-grade squamous intraepithelial lesions to therapeutic HPV16 vaccination

Expression of coinhibitory receptors on T cells in the microenvironment of usual vulvar intraepithelial neoplasia is related to proinflammatory effector T cells and an increased recurrence‐free survival

Immune-based biomarker accurately predicts response to imiquimod immunotherapy in cervical high-grade squamous intraepithelial lesions

Clinical Characteristics Associated With Development of Recurrence and Progression in Usual-Type Vulvar Intraepithelial Neoplasia

Human Papillomavirus Downregulates the Expression of IFITM1 and RIPK3 to Escape from IFNγ- and TNFα-Mediated Antiproliferative Effects and Necroptosis

366 Core set of patient-reported outcomes in vulvar cancer a Delphi study among patients, partners and health care providers

Treatment failure in patients with HPV 16-induced vulvar intraepithelial neoplasia: understanding different clinical responses to immunotherapy

Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response

1020 Prognostic and therapeutic implications of radiologic-clinical discrepancy in parametrial invasion assessments prior to primary radical hysterectomy in cervical cancer

EP094/#1572 Unraveling the complexities of cervical cancer: exploration of molecular mechanisms and immunological dichotomies between squamous cell carcinoma and adenocarcinoma

Unraveling Differences in Molecular Mechanisms and Immunological Contrasts between Squamous Cell Carcinoma and Adenocarcinoma of the Cervix

EP330/#475 Immune-based biomarker accurately predicts response to imiquimod immunotherapy in cervical high-grade squamous intraepithelial lesions

Treatment with methotrexate of a cornual pregnancy following endometrial resection

The immune cell infiltrate in the microenvironment of vulvar Paget disease

The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NF[kappa]B activation

Human papillomavirus (HPV) downregulates the expression of IFITM1 and RIPK3 to escape from IFNγ and TNFα-mediated anti-proliferative effects and necroptosis

Treatment with methotrexate of a cornual pregnancy following endometrial resection

285 Risk factors for wound complications in vulvar cancer surgery and the impact of reconstructive surgery

339 Improving patient counseling before and during imiquimod treatment for cervical high-grade squamous intraepithelial lesions: a qualitative study

Suchergebnisse filtern